vs
合众银行（HBCP）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是合众银行的2.0倍（$75.5M vs $38.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.4%）
该企业是总部位于美国明尼苏达州明尼阿波利斯、在特拉华州注册的跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行，主营银行、投资、抵押贷款等各类金融业务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HBCP vs PBYI — 直观对比
营收规模更大
PBYI
是对方的2.0倍
$38.2M
两年增速更快
PBYI
近两年复合增速
7.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.2M | $75.5M |
| 净利润 | $11.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 29.7% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $1.45 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBCPPBYI
| Q1 26 | $38.2M | — | ||
| Q4 25 | $38.0M | $75.5M | ||
| Q3 25 | $37.8M | $54.5M | ||
| Q2 25 | $37.1M | $52.4M | ||
| Q1 25 | $35.8M | $46.0M | ||
| Q4 24 | $35.2M | $59.1M | ||
| Q3 24 | $34.1M | $80.5M | ||
| Q2 24 | $33.1M | $47.1M |
净利润HBCPPBYI
| Q1 26 | $11.4M | — | ||
| Q4 25 | $11.4M | — | ||
| Q3 25 | $12.4M | $8.8M | ||
| Q2 25 | $11.3M | $5.9M | ||
| Q1 25 | $11.0M | $3.0M | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $9.4M | $20.3M | ||
| Q2 24 | $8.1M | $-4.5M |
毛利率HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | 38.2% | 22.7% | ||
| Q3 25 | 41.1% | 17.6% | ||
| Q2 25 | 38.2% | 12.7% | ||
| Q1 25 | 38.6% | 8.7% | ||
| Q4 24 | 34.0% | 22.6% | ||
| Q3 24 | 34.3% | 27.4% | ||
| Q2 24 | 30.4% | -4.6% |
净利率HBCPPBYI
| Q1 26 | 29.7% | — | ||
| Q4 25 | 30.0% | — | ||
| Q3 25 | 32.7% | 16.2% | ||
| Q2 25 | 30.6% | 11.2% | ||
| Q1 25 | 30.7% | 6.5% | ||
| Q4 24 | 27.5% | — | ||
| Q3 24 | 27.7% | 25.2% | ||
| Q2 24 | 24.5% | -9.6% |
每股收益（稀释后）HBCPPBYI
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.46 | $0.26 | ||
| Q3 25 | $1.59 | $0.17 | ||
| Q2 25 | $1.45 | $0.12 | ||
| Q1 25 | $1.37 | $0.06 | ||
| Q4 24 | $1.21 | $0.40 | ||
| Q3 24 | $1.18 | $0.41 | ||
| Q2 24 | $1.02 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $223.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $444.4M | $130.3M |
| 总资产 | $3.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HBCPPBYI
| Q1 26 | $223.5M | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益HBCPPBYI
| Q1 26 | $444.4M | — | ||
| Q4 25 | $435.1M | $130.3M | ||
| Q3 25 | $423.0M | $115.3M | ||
| Q2 25 | $408.8M | $104.7M | ||
| Q1 25 | $402.8M | $97.1M | ||
| Q4 24 | $396.1M | $92.1M | ||
| Q3 24 | $393.5M | $71.1M | ||
| Q2 24 | $375.8M | $48.5M |
总资产HBCPPBYI
| Q1 26 | $3.6B | — | ||
| Q4 25 | $3.5B | $216.3M | ||
| Q3 25 | $3.5B | $202.9M | ||
| Q2 25 | $3.5B | $194.9M | ||
| Q1 25 | $3.5B | $196.2M | ||
| Q4 24 | $3.4B | $213.3M | ||
| Q3 24 | $3.4B | $220.7M | ||
| Q2 24 | $3.4B | $205.0M |
负债/权益比HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | $54.5M | $14.4M | ||
| Q3 25 | $21.5M | $9.7M | ||
| Q2 25 | $8.7M | $14.1M | ||
| Q1 25 | $12.6M | $3.6M | ||
| Q4 24 | $48.7M | $15.6M | ||
| Q3 24 | $17.6M | $11.0M | ||
| Q2 24 | $15.0M | $1.0M |
自由现金流HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | $44.3M | $14.4M | ||
| Q3 25 | $20.7M | $9.7M | ||
| Q2 25 | $7.9M | $14.1M | ||
| Q1 25 | $8.7M | $3.6M | ||
| Q4 24 | $44.7M | $15.6M | ||
| Q3 24 | $17.0M | $11.0M | ||
| Q2 24 | $13.4M | $1.0M |
自由现金流率HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | 19.1% | ||
| Q3 25 | 54.6% | 17.7% | ||
| Q2 25 | 21.3% | 26.8% | ||
| Q1 25 | 24.3% | 7.7% | ||
| Q4 24 | 126.9% | 26.4% | ||
| Q3 24 | 49.8% | 13.7% | ||
| Q2 24 | 40.3% | 2.1% |
资本支出强度HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | 26.7% | 0.0% | ||
| Q3 25 | 2.2% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 10.8% | 0.1% | ||
| Q4 24 | 11.5% | 0.0% | ||
| Q3 24 | 1.9% | 0.0% | ||
| Q2 24 | 4.9% | 0.0% |
现金转化率HBCPPBYI
| Q1 26 | — | — | ||
| Q4 25 | 4.78× | — | ||
| Q3 25 | 1.74× | 1.10× | ||
| Q2 25 | 0.77× | 2.41× | ||
| Q1 25 | 1.15× | 1.21× | ||
| Q4 24 | 5.04× | — | ||
| Q3 24 | 1.87× | 0.54× | ||
| Q2 24 | 1.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBCP
| Net Interest Income | $34.5M | 90% |
| Noninterest Income | $3.7M | 10% |
PBYI
暂无分部数据
